Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 30-Apr-24 6:34 PM View:  | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 30-Apr-24 | Planned Option Sale | 238 | $10.03 | $2,386.43 | (6%) 4.03K to 3.8K | |
| 30-Apr-24 6:34 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 26-Apr-24 | Option Exercise | 868 | -- | -- | 27% 3.17K to 4.03K | |
| 23-Jan-24 7:11 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 23-Jan-24 | Option Sale | 28,000 | $0.37 | $10,360.00 | (1%) 2.25M to 2.23M | |
| 23-Jan-24 7:17 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 22-Jan-24 | Planned Option Sale | 137,390 | $0.36 | $49,460.40 | (28%) 493.82K to 356.43K | |
| 23-Jan-24 7:13 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 22-Jan-24 | Planned Option Sale | 21,526 | $0.36 | $7,749.36 | (18%) 116.51K to 94.98K | |
| 23-Jan-24 7:15 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 22-Jan-24 | Planned Option Sale | 21,287 | $0.36 | $7,663.32 | (12%) 172.31K to 151.03K | |
| 23-Jan-24 7:15 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 20-Jan-24 | Option Exercise | 59,345 | -- | -- | 53% 112.97K to 172.31K | |
| 23-Jan-24 7:13 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 20-Jan-24 | Option Exercise | 60,012 | -- | -- | 106% 56.5K to 116.51K | |
| 23-Jan-24 7:19 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 20-Jan-24 | Option Exercise | 116,690 | -- | -- | 23% 497.48K to 614.17K | |
| 23-Jan-24 7:17 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 20-Jan-24 | Option Exercise | 266,720 | -- | -- | 117% 227.1K to 493.82K | |
| 23-Jan-24 7:11 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 20-Jan-24 | Option Exercise | 75,015 | -- | -- | 3% 2.18M to 2.25M | |
| 06-Nov-23 5:09 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 03-Nov-23 | Planned Option Sale | 16,023 | $0.40 | $6,409.20 | (12%) 128.99K to 112.97K | |
| 06-Nov-23 5:07 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 03-Nov-23 | Planned Option Sale | 125,025 | $0.40 | $50,010.00 | (36%) 352.13K to 227.1K | |
| 06-Nov-23 5:04 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 02-Nov-23 | Option Exercise | 108,188 | -- | -- | 28% 389.29K to 497.48K | |
| 06-Nov-23 5:07 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 02-Nov-23 | Option Exercise | 283,390 | -- | -- | 412% 68.74K to 352.13K | |
| 06-Nov-23 5:09 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 02-Nov-23 | Option Exercise | 55,077 | -- | -- | 75% 73.92K to 128.99K | |
| 05-Sep-23 4:15 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 31-Aug-23 | Grant | 5,175 | $0.39 | $2,018.25 | < 1% 2.17M to 2.18M | |
| 05-Sep-23 4:15 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 31-Aug-23 | Grant | 5,951 | $0.39 | $2,320.89 | 2% 383.34K to 389.29K | |
| 05-Sep-23 4:16 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 31-Aug-23 | Grant | 5,443 | $0.39 | $2,122.77 | 8% 68.47K to 73.92K | |
| 22-Aug-23 4:10 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 18-Aug-23 | Grant | 90,000 | $0.48 | $43,200.00 | 31% 293.34K to 383.34K | |
| 09-Jun-23 4:15 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 08-Jun-23 | Planned Option Sale | 13,361 | $0.75 | $10,020.80 | (16%) 81.83K to 68.47K | |
| 09-Jun-23 4:15 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 07-Jun-23 | Option Exercise | 31,771 | -- | -- | 63% 50.06K to 81.83K | |
| 09-Jun-23 4:15 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 07-Jun-23 | Option Exercise | 4,872 | -- | -- | < 1% 2.17M to 2.17M | |
| 09-Jun-23 4:15 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 07-Jun-23 | Option Exercise | 47,726 | -- | -- | 19% 245.61K to 293.34K | |
| 09-Jun-23 4:20 PM View: | Barton Shane VP & Corporate Controller | Precision Biosciences Inc (DTIL) | 07-Jun-23 | Option Exercise | 6,060 | -- | -- | 28% 21.44K to 27.5K | |
| 28-Apr-23 4:53 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 27-Apr-23 | Planned Option Sale | 7,771 | $0.79 | $6,139.09 | (12%) 64.27K to 56.5K | |
| 28-Apr-23 4:53 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 26-Apr-23 | Option Exercise | 26,027 | -- | -- | 68% 38.24K to 64.27K | |
| 13-Apr-23 4:15 PM View: | Buehler Kevin Director | Precision Biosciences Inc (DTIL) | 11-Apr-23 | Option Exercise | 5,701 | -- | -- | 100% 0 to 5.7K | |
| 23-Mar-23 4:00 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 22-Mar-23 | Planned Option Sale | 46,999 | $0.82 | $38,539.20 | (41%) 115.74K to 68.74K | |
| 23-Mar-23 4:00 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 21-Mar-23 | Option Exercise | 102,535 | -- | -- | 777% 13.2K to 115.74K | |
| 21-Mar-23 9:19 AM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 17-Mar-23 | Private Purchase | 20,000 | $0.86 | $17,200.00 | 9% 225.61K to 245.61K | |
| 07-Mar-23 5:16 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 06-Mar-23 | Planned Option Sale | 9,473 | $1.07 | $10,136.10 | (20%) 47.71K to 38.24K | |
| 07-Mar-23 5:19 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 06-Mar-23 | Planned Option Sale | 12,172 | $1.07 | $13,024.00 | (20%) 62.23K to 50.06K | |
| 07-Mar-23 5:08 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 03-Mar-23 | Option Exercise | 51,071 | -- | -- | 29% 174.54K to 225.61K | |
| 07-Mar-23 5:04 PM View: | Barton Shane VP & Corporate Controller | Precision Biosciences Inc (DTIL) | 03-Mar-23 | Option Exercise | 12,722 | -- | -- | 146% 8.7K to 21.42K | |
| 07-Mar-23 5:16 PM View: | List Alan Chief Medical Officer | Precision Biosciences Inc (DTIL) | 03-Mar-23 | Option Exercise | 29,453 | -- | -- | 161% 18.26K to 47.71K | |
| 07-Mar-23 5:19 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 03-Mar-23 | Option Exercise | 27,558 | -- | -- | 79% 34.68K to 62.23K | |
| 07-Mar-23 5:12 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 03-Mar-23 | Option Exercise | 15,576 | -- | -- | < 1% 2.15M to 2.17M | |
| 07-Mar-23 5:19 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 28-Feb-23 | Grant | 2,163 | $0.95 | $2,054.85 | 7% 32.51K to 34.68K | |
| 07-Mar-23 5:12 PM View: | Smith J. Jefferson Chief Research Officer | Precision Biosciences Inc (DTIL) | 28-Feb-23 | Grant | 12,157 | $0.95 | $11,549.10 | < 1% 2.14M to 2.15M | |
| 07-Mar-23 5:08 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 28-Feb-23 | Grant | 11,605 | $0.95 | $11,024.80 | 7% 162.94K to 174.54K | |
| 18-Oct-22 4:13 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 17-Oct-22 | Planned Option Sale | 11,006 | $1.32 | $14,527.90 | (45%) 24.21K to 13.2K | |
| 18-Oct-22 4:13 PM View: | Amoroso Michael President and CEO Director | Precision Biosciences Inc (DTIL) | 15-Oct-22 | Option Exercise | 24,208 | -- | -- | 100% 0 to 24.21K | |
| 26-Sep-22 4:10 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 23-Sep-22 | Purchase | 8,200 | $1.23 | $10,086.00 | 5% 154.74K to 162.94K | |
| 26-Sep-22 4:10 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 22-Sep-22 | Private Purchase | 37,037 | $1.34 | $49,629.60 | 31% 117.7K to 154.74K | |
| 24-Jun-22 8:59 AM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 22-Jun-22 | Private Purchase | 33,784 | $1.50 | $50,676.00 | 40% 83.92K to 117.7K | |
| 09-Jun-22 4:36 PM View: | Scimeca Dario General Counsel and Secretary | Precision Biosciences Inc (DTIL) | 08-Jun-22 | Planned Option Sale | 9,833 | $2.06 | $20,256.00 | (23%) 42.35K to 32.51K | |
| 09-Jun-22 4:42 PM View: | Jantz Derek Chief Scientific Officer Director | Precision Biosciences Inc (DTIL) | 08-Jun-22 | Planned Option Sale | 18,849 | $2.06 | $38,828.90 | (< 1%) 4.07M to 4.06M | |
| 09-Jun-22 4:30 PM View: | Kelly John Alexander Chief Financial Officer | Precision Biosciences Inc (DTIL) | 07-Jun-22 | Option Exercise | 47,728 | -- | -- | 132% 36.19K to 83.92K | |
| 09-Jun-22 4:26 PM View: | Barton Shane VP & Corporate Controller | Precision Biosciences Inc (DTIL) | 07-Jun-22 | Option Exercise | 6,061 | -- | -- | 228% 2.66K to 8.72K |
